Vasopressin: Clinical Trials

60 trials of Vasopressin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

31 completed, 10 unknown, 6 recruiting, 5 withdrawn. 20 Not applicable, 16 Phase 4, 11 Phase 2, 11 Phase 3, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable20Completed 11, Unknown 5, Recruiting 2, Terminated 1, Withdrawn 1
Phase 416Completed 6, Unknown 3, Withdrawn 3, Recruiting 2, Active not recruiting 1, Enrolling by invitation 1
Phase 211Completed 7, Recruiting 2, Not yet recruiting 1, Withdrawn 1
Phase 311Completed 8, Active not recruiting 1, Unknown 1, Withdrawn 1
Phase 13Completed 2, Active not recruiting 1
Early Phase 12Completed 1, Terminated 1

Follow Vasopressin: new trials by email Literature Review of Vasopressin trials Research Report on Vasopressin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Vasopressin Versus Norepinephrine on Post-operative Mean Pulmonary Arterial Pressure Following Pulmonary Endarterectomy Surgery,
Vasopressin, Norepinephrine - Anesthesia, Pulmonary Hypertension
Phase 2Not yet recruitingFondation Hôpital Saint-Joseph902026-08-012026-06-02
Phenotype Guided Vasoactive Medication During Kidney Transplantation
Phenotype-Guided Vasoactive Management - Kidney Transplant, Fluid Management
Phase 4Enrolling by invitationJennifer Cutler2552026-06-012026-10-22
Vasopressin Hemodynamic Response as a Septic Shock Subphenotype Indicator
Vasopressin - Shock, Septic
TerminatedThe Cleveland Clinic22025-10-012026-02-19
Early Versus Late Adjunctive Vasopressin in Septic Shock
vasopressin - early initiation, vasopressin - standard initiation - Sepsis, Septic Shock
Phase 4RecruitingThe Cleveland Clinic3002025-04-292026-08-31
Use of Vasopressin in Patients at High Risk of Acute Kidney Injury Admitted to the ICU
Vasopressin, 0,9% saline solution - Critical Illness
Phase 2RecruitingHospital do Coracao602025-04-102025-04-13
Registry of Patients in Shock Treated With Vasopressin
Vasopressin - Vasopressin Causing Adverse Effects in Therapeutic Use, Shock
UnknownHospital Universitario 12 de Octubre5002024-07-092024-07-15
Tranexamic Acid in Vaginal Reconstructive Surgery
Tranexamic acid, Vasopressin, NaCl 0.9% - Pelvic Organ Prolapse
Phase 4WithdrawnThe University of Texas Medical Branch, Galveston2024-07-012025-01-31
CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial
Calcium Gluconate, Vasopressin, saline placebo - Trauma, Hemorrhage
Phase 2RecruitingJason Sperry10502024-06-302026-09-29
Vasopressin Versus Tranexamic Acid for Control of Blood Loss Related to Abdominal Hysterectomy
Vasopressin, Tranexamic acid, Saline - Uterine Surgery
Phase 4UnknownAl-Azhar University3872024-04-012024-03-06
The Effects of Oral Vasopressin on Attention Control: An Eye-tracking Study
Vasopressin, Placebo - Healthy
Not applicableUnknownUniversity of Electronic Science and Technology of China802024-03-052024-04-11
Oral Vasopressin Modulates Neural Responses to Looming Visual Stimuli: An Eye-tracking Study
Vasopressin, Placebo - Healthy
Not applicableUnknownUniversity of Electronic Science and Technology of China802024-03-052024-04-11
Vasopressin for Septic Shock Pragmatic Trial
Vasopressin, Recommendation to use a lower initiation threshold for vasopressin, Recommendation to use a higher initiation threshold for vasopressin - Septic Shock
Phase 4CompletedIntermountain Health Care, Inc.39592024-02-012026-08-03
The Effect of Vasopressor Therapy on Renal Perfusion in Septic Shock
Angiotensin II, Vasopressin, Norepinephrine - Septic Shock, Acute Kidney Injury
Not applicableRecruitingKing's College Hospital NHS Trust452024-01-052025-04-04
Vasopressin vs. Epinephrine During Neonatal Cardiopulmonary Resuscitation
Vasopressin, Epinephrine - Cardiac Arrest Neonatal
Phase 1Active not recruitingUniversity of Alberta82023-11-272026-04-09
Methods Decreasing Bleeding in Open Myomectomy
Misoprostol, Tourniquet, Carbetocin - Misoprostol Allergy, Oxytocin Allergy
Phase 4UnknownCairo University1052023-03-152023-04-10
Evaluation of the Superiority of VAsopressin Versus NOradrenaline in the Management of Patients at Risk of Kidney Failure Undergoing Cardiac Surgery With Extracorporeal Circulation
Vasopressin, Norepinephrine, Collection of clinical data - Scheduled Cardiac Surgery With Extracorporeal Circulation, Vasoplegic Syndrome
Phase 3Active not recruitingCentre Hospitalier Universitaire Dijon8402023-01-022025-12-22
Noradrenaline Versus Glypressin for Prevention of Hypotension After Deflation of Tourniquet in Knee Arthroplasty
Saline, Norepinephrine, glypressin - Norepinephrine, Glypressin, Tourniquet Deflation, Hypotension
Not applicableCompletedTanta University1352022-12-012023-11-22
Hypotension in the Weaning From Vasopressor Drugs
Norepinephrine, Vasopressin - Septic Shock
Phase 4CompletedHospital Nossa Senhora da Conceicao782022-05-012025-03-14
Angiotensin 2 for AKI After OLT
Angiotensin II, Norepinephrine - Cirrhosis, Liver, End Stage Liver DIsease
Phase 4Active not recruitingUniversity of California, Los Angeles302022-04-082026-06-12
Efficacy and Safety of Vasopressin Versus Terlipressin as a Second Vasopressor in Critically Ill Cirrhotics With Septic Shock- the VITEL-C Trial
Terlipressin, vasopressin - Septic Shock, Cirrhosis, Liver
Not applicableUnknownInstitute of Liver and Biliary Sciences, India1002022-04-052022-04-07

Showing 20 of 60. Sign in to see all of them.

Conditions studied

Diabetes Insipidus (31)  ·  Shock, Septic (12)  ·  Hypotension (8)  ·  Shock (7)  ·  Hemorrhage (5)  ·  Acute Kidney Injury (4)  ·  Myoma (3)  ·  Sepsis (3)  ·  Wounds and Injuries (3)  ·  Autism Spectrum Disorder (2)  ·  Blood Loss, Surgical (2)  ·  Heart Arrest (2)  ·  Liver Cirrhosis (2)  ·  Shock, Hemorrhagic (2)  ·  Shock, Traumatic (2)

Sponsors

University of Electronic Science and Technology of China (5)  ·  The Cleveland Clinic (3)  ·  Seoul National University Hospital (2)  ·  Stanford University (2)  ·  University of Sao Paulo (2)  ·  Al-Azhar University (1)  ·  Ascher-Walsh, Charles, M.D. (1)  ·  Aswan University Hospital (1)  ·  Baylor College of Medicine (1)  ·  Brigham and Women's Hospital (1)  ·  CHA University (1)  ·  Cairo University (1)  ·  Centre Hospitalier Universitaire Dijon (1)  ·  Fondation Hôpital Saint-Joseph (1)  ·  Francois Lamontagne (1)

Countries

United States (26)  ·  China (5)  ·  South Korea (5)  ·  Brazil (4)  ·  Canada (3)  ·  Egypt (3)  ·  France (2)  ·  Italy (2)  ·  Austria (1)  ·  Germany (1)  ·  India (1)  ·  Jamaica (1)  ·  Singapore (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

Benjamin Becker, Dr (2)  ·  Keith Kendrick, PhD (2)  ·  Andrea Morelli, MD (1)  ·  Ann Tran, MD (1)  ·  Antonio Y Hardan, MD (1)  ·  Carlo Manno, MD (1)  ·  Carrie A Sims, MD, MS (1)  ·  Cassio Mallmann, MD (1)  ·  Charles Ascher-Walsh, MD, MPH (1)  ·  Cristiane M Zambolim, MD (1)  ·  Danielle R Rios, M.D. (1)  ·  Drayton Hammond, Pharm.D. (1)  ·  Francois Lamontagne, MD (1)  ·  Georg Schmolzer (1)  ·  Gokhan Kilic, MD (1)

Results publications

PMID 18305265, PMID 25947955, PMID 29784057, PMID 11529214, PMID 11555538, PMID 12519925, PMID 12794416, PMID 16616623, PMID 16931974, PMID 16931995, PMID 19155900, PMID 19534818, PMID 19664253, PMID 19841897, PMID 19926252, PMID 20129334, PMID 21161222, PMID 21354681, PMID 22353644, PMID 22518026, PMID 23796235, PMID 23876539, PMID 25641242, PMID 26125087, PMID 26903338, PMID 27398737, PMID 27483065, PMID 27841822, PMID 28618919, PMID 28750598, PMID 29319721, PMID 29328496, PMID 29600824, PMID 29859008, PMID 31461138, PMID 31609774, PMID 31958982, PMID 31970567, PMID 31983763, PMID 33977793, PMID 34404892, PMID 34582425, PMID 34599691, PMID 34605781, PMID 34752520, PMID 36115677, PMID 37462430, PMID 37510705, PMID 37663146, PMID 37811711

NIH funding

2025 (1), R21HD078778 (1), R21MH100387 (1), UL1TR001449 (1)